Straits Times Index
3,280.10 -7.65 (-0.23%) S&P 500
5,099.96 +51.54 (+1.02%) Dow
38,239.66 +153.86 (+0.40%) Nasdaq
15,927.90 +316.10 (+2.02%) Bitcoin USD
63,728.67 +350.31 (+0.55%) CMC Crypto 200
1,394.70 -1.84 (-0.13%)
Nuwellis, Inc. (NUWE)
After hours:
- GlobeNewswire
Nuwellis Announces Pricing of $2.7 Million Public Offering
MINNEAPOLIS, April 26, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid overload, today announced the pricing of a public offering of 11,250,000 shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to an aggregate of 16,875,000 shares of its common stock at a combined public offering price $0.24 per share (or pre-funded warrant in lie
- GlobeNewswire
Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health
MINNEAPOLIS, April 09, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced that Detroit, Michigan-based health system, Henry Ford Health, has begun offering ultrafiltration therapy to heart failure patients suffering from fluid overload using the company’s Aquadex SmartFlow system as part of Nuwellis’ pivotal REVERSE-HF clinical study. “We are excited to study the impact of Aquadex SmartFlow therapy on our heart failure patients who are suffering from severe fluid overload,” s
- Simply Wall St.
Nuwellis Full Year 2023 Earnings: EPS Beats Expectations
Nuwellis ( NASDAQ:NUWE ) Full Year 2023 Results Key Financial Results Revenue: US$8.86m (up 3.8% from FY 2022). Net...
